[Immunocomplexes in pediatrics. II: Investigation in neurological patients (author's transl)]. 1980

A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares

Circulating immune complexes were investigated by polyethilene-glycol precipitation in the serum of 101 neurological patients from four months to 15 years old. The test was positive in 21 cases (20.7%) and 24 normal controls were negative. The polyethilene-glycol positive group had a lower seric C'3 than negative group [p < 0.02]. The highest positivity was found in meningoencephalitic infections with sequelae [6/6: 100%] and in cerebral atrophy or very important mental deficiency [11/30: 37%]. The polyethilene-glycol test was not correlated with seric IgG levels, neither in positive nor in negative groups. All patients were receiving anticonvulsivant treatment. The detection of circulating immune complexes may be the result of either brain tissue injury or of another immunological disturb found in epilepsy. There was no relationship between seric immunocomplexes and severity of epileptic disorders and it is not likely that they have any influence over seizures. The role played by anticonvulsivant drugs remains uncleared and further studies are needed.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005260 Female Females

Related Publications

A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
July 1980, Anales espanoles de pediatria,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
October 1979, Haematologica,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
July 1976, The Japanese journal of antibiotics,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
September 1974, Anales espanoles de pediatria,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
May 1982, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
June 1975, Monatsschrift fur Kinderheilkunde,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
October 1981, Casopis lekaru ceskych,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
January 1981, Padiatrie und Padologie,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
March 1981, Annales de pediatrie,
A Blanco, and R Palencia, and P Solís, and J A Guisasola, and E Sánchez Villares
December 1979, Lijecnicki vjesnik,
Copied contents to your clipboard!